At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4599 Weight Loss Drugs
Trading 12-26 11:14:49 EST
1,499.19
-6.57
-0.44%
High1,510.74Low1,494.90Vol13.49M
Open1,506.38D1 Closing1,505.76Amplitude1.05%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O837.26MT/O Rate--Tradable Shares0.00
P/B9.880425ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Eli Lilly Pays $55 Million to ABL Bio as Part of Upfront Payment, Equity Investment
MT Newswires Live  ·  12-26 18:13
Eli Lilly Pays $55 Million to ABL Bio as Part of Upfront Payment, Equity Investment
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)?
Simply Wall St.  ·  12-26 10:21
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)?
Is Pfizer a Quiet Opportunity After a 41% Three Year Share Price Slide?
Simply Wall St.  ·  12-26 03:23
Is Pfizer a Quiet Opportunity After a 41% Three Year Share Price Slide?
Bollywood Stars and 40% Price Cuts: Eli Lilly and Novo Nordisk Battle for India's Weight-Loss Drug Market
Deep News  ·  12-25 08:19
Bollywood Stars and 40% Price Cuts: Eli Lilly and Novo Nordisk Battle for India's Weight-Loss Drug Market
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval
Benzinga  ·  12-25 01:31
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval
Pfizer Receives Tax Demand Order Worth 12.7 Million Rupees
Reuters  ·  12-24 21:07
Pfizer Receives Tax Demand Order Worth 12.7 Million Rupees
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Wednesday; AST SpaceMobile, Novo Nordisk to Advance
MT Newswires Live  ·  12-24 19:31
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Wednesday; AST SpaceMobile, Novo Nordisk to Advance
Telescope Innovations posts FY 2025 expenses of CAD 7.3 million, up 26 percent
Reuters  ·  12-24 07:36
Telescope Innovations posts FY 2025 expenses of CAD 7.3 million, up 26 percent
Pfizer Inc. Stock Underperforms Tuesday When Compared To Competitors
Dow Jones  ·  12-24 05:38
Pfizer Inc. Stock Underperforms Tuesday When Compared To Competitors
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Benzinga_recent_news  ·  12-24 03:04
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?
Benzinga_recent_news  ·  12-24 02:18
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?
What's Going On With Eli Lilly Stock Today?
Benzinga_recent_news  ·  12-24 01:25
What's Going On With Eli Lilly Stock Today?
Nordic Shares Rise; Novo Nordisk Series B Climbs Highest
Dow Jones  ·  12-24 01:06
Nordic Shares Rise; Novo Nordisk Series B Climbs Highest
Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus
Benzinga_recent_news  ·  12-24 01:06
Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus
Pfizer says patient dies after receiving hemophilia drug in trial
Reuters  ·  12-24 00:20
Pfizer says patient dies after receiving hemophilia drug in trial
BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy
Reuters  ·  12-24 00:20
BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy
BRIEF-Participant Death Reported in Pfizer Hemophilia Trial, Letter Shows
Reuters  ·  12-24 00:17
BRIEF-Participant Death Reported in Pfizer Hemophilia Trial, Letter Shows
BRIEF-Pfizer Says Does Not Anticipate Any Impact To Safety For Patients Treated With Approved Marstacimab
Reuters  ·  12-24
BRIEF-Pfizer Says Does Not Anticipate Any Impact To Safety For Patients Treated With Approved Marstacimab
Pfizer: Participant in Long-Term Extension Trial Studying Marstacimab in People Living With Hemophilia a/B With/Without Inhibitors Passed Away in Dec
THOMSON REUTERS  ·  12-24
Pfizer: Participant in Long-Term Extension Trial Studying Marstacimab in People Living With Hemophilia a/B With/Without Inhibitors Passed Away in Dec
Pfizer: Safety and Well-Being of Participants in Our Clinical Trials Remain Our Highest Priority, and We Are Committed to Transparency
THOMSON REUTERS  ·  12-23
Pfizer: Safety and Well-Being of Participants in Our Clinical Trials Remain Our Highest Priority, and We Are Committed to Transparency

Introduction

Company Name.
BK4599
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--